Rectus sheath catheters after midline abdominal surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing median laparotomy are randomized to receive either ropivacaine via rectus sheath catheters or placebo as part of a multimodal analgesia plan after surgery. The trial uses a placebo-controlled, blinded design with randomization performed on the day of surgery and standard anesthesia and monitoring. Primary outcomes include maximum postoperative pain, QoR-15GE recovery score, and opioid use in the first 72 hours. The study aims to determine if rectus sheath catheters add meaningful analgesia in patients for whom thoracic epidurals may be unsuitable or refused.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Median laparotomy
* Age over 18 years
* Informed consent has been obtained

Exclusion Criteria:

* Local signs of inflammation
* known allergy to local anesthetics used
* chronic pain syndrome
* drug addiction
* post-operative ventilation that cannot be completed on the day of surgery
* lack of consent or cooperation
* pregnancy
* participation in another medical study
* sepsis

Where it's running

• Asklepios Medical Center Uckermark
  Schwedt, Brandenburg, Germany Recruiting

Study contacts

• Principal investigator: Ronald Seidel, Dr.med. — Asklepios Klinikum Uckermark
• Study coordinator: Ronald Seidel, Dr.med.
• Email: ro.seidel@asklepios.com
• Phone: +49 3332 534521

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exercise after pelvic radiation to see if it lowers colorectal cancer risk

  This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.

  Recruiting at 2 sites City of Hope Medical Center · Duarte, California and 1 other locations · NCT07790718

• Teach-back education for people with ostomies to improve self-care and adjustment

  This study tests whether teaching ostomy care using the Teach-back method helps adults with ostomies feel more able to care for themselves and adjust, and reduces anxiety.

  Recruiting Saglik Bilimleri Universitesi · Istanbul, Üsküdar · NCT07788079

• Irreversible Electroporation for Recurrent Pelvic Tumors

  This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.

  Recruiting Amsterdam UMC, location VUmc · Amsterdam, North Holland · NCT07782164

• Smart Symptom Tracking with ALEX for GI Health in Young Adults

  This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT07618273

• Culturally adapted online genetic counseling and testing education for African American cancer survivors

  We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.

  Recruiting Barbara Ann Karmanos Cancer Institute · Detroit, Michigan · NCT07436078

• Zanidatamab given before surgery for HER2-positive colon or rectal cancer

  This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.

  Recruiting at 4 sites Phase 2 Emory University · Atlanta, Georgia and 3 other locations · NCT07405476

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.